Dr Paul Porter, Director (MBBS FRACP) is a founder and Director of Freeman Road Pty Ltd, an Australian company that specialises in early stage biomedical investments with an emphasis on global research and development collaborations. Freeman Road has investments in companies across Australia, South East Asia, Europe and the USA. Paul has established a research unit specialising in novel biometric diagnostic technology and algorithm development, with active programs targeting Respiratory disease and Mental Health Disorders in children and adolescents. He is lead Scientific Advisor to ResApp Health, an ASX listed company currently undertaking a multi-centre FDA approval study in the US. Paul is also an experienced medical researcher, lecturer, director of training and paediatric physician at two major paediatric hospitals in Western Australia. He is member of a Human Research and Ethics Committee and the Clinical Senate of Western Australia. He is passionate about supporting advances in healthcare in the developing world.